Daniel E. Geffken - 29 Nov 2021 Form 4 Insider Report for Eloxx Pharmaceuticals, Inc.

Role
INTERIM CFO
Signature
/s/ Daniel E. Geffken
Issuer symbol
N/A
Transactions as of
29 Nov 2021
Net transactions value
+$36,000
Form type
4
Filing time
01 Dec 2021, 10:06:56 UTC
Previous filing
12 Oct 2021
Next filing
09 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELOX Common Stock Purchase $36,000 +50,000 $0.7200 50,000 29 Nov 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Price represents the average purchase price per share.